Trials / Completed
CompletedNCT01213251
Post-Myocardial Infarction Remodeling Prevention Therapy
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 129 (actual)
- Sponsor
- Medtronic Cardiac Rhythm and Heart Failure · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to demonstrate the feasibility of pacing as a therapy to prevent adverse remodeling of the myocardium following an acute myocardial infarction (MI) in patients at highest risk for adverse myocardial remodeling.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Single Site Pacing | Subjects will be implanted with a CRT-D that delivers pacing via the Left Ventricular lead. |
| DEVICE | Dual Site Pacing | Subjects will be implanted with a CRT-D that delivers pacing via the Left Ventricular and Right Ventricular lead. |
Timeline
- Start date
- 2010-12-01
- Primary completion
- 2015-10-01
- Completion
- 2016-04-01
- First posted
- 2010-10-01
- Last updated
- 2016-12-15
- Results posted
- 2016-12-15
Locations
26 sites across 7 countries: United States, Denmark, France, Germany, Hungary, Saudi Arabia, Slovakia
Source: ClinicalTrials.gov record NCT01213251. Inclusion in this directory is not an endorsement.